“A case for biologics (infusion vs subcutaneous) must be made on accurate real-world economic analysis” Heald et al (2021).
“This significant reduction (by Fisher’s exact test p = 0.0001) suggests that employing a passive blood diversion device in addition to targeted education may decrease FPBCs; antibiotics overuse, costs, and return visits in the pediatric ED setting” Ostwald et al (2021).
“Our results showed that 0.9% NaCl and 0.45% NaCl solutions might be the safest and the most appropriate fluids to maintain normal plasma osmolality in medical situations requiring fluid therapy with high or maintenance rates, respectively” Keskin et al (2021).
“Potential locations were identified, and the team decided to use a temporary structure located outside the hospital near the emergency department entrance” Harris et al (2021).
“Use of (Taurolock-hep500™) for temporary hemodialysis catheters was associated with lower levels of inflammation markers and lower incidence of CRBSI and better catheter performance” Ezzat et al (2021).
“This article describes how one large university health board in Wales implemented a change in products and practice and explores the issues around adopting and using CE-marked pre-filled, sterile syringes of 0.9% sodium chloride in place of manually drawing up an IV flush (the CE mark indicates devices that conforms with European legal requirements)” Lee and Terry (2021).
“The aim of this review was to perform a critical reappraisal of the real-world evidence supporting administration by prolonged infusion of novel beta-lactams for the management of multidrug-resistant Gram-negative infections” Gatti and Pea (2021).